Vanda Pharmaceuticals
VNDA
#7890
Rank
A$0.40 B
Marketcap
$6.96
Share price
-5.96%
Change (1 day)
3.87%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2024 (TTM): -A$55.65 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.19 Billion. In 2023 the company made an earning of -A$21.96 Million a decrease over its 2022 earnings that were of A$9.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$55.65 Million153.41%
2023 -A$21.96 Million-320.45%
2022 A$9.96 M-84.99%
2021 A$66.35 M54.8%
2020 A$42.86 M19.42%
2019 A$35.89 M4.93%
2018 A$34.21 M-228.6%
2017 -A$26.61 Million-8.98%
2016 -A$29.23 Million-53.79%
2015 -A$63.25 Million-30.18%
2014 -A$90.59 Million173.08%
2013 -A$33.17 Million-25.33%
2012 -A$44.43 Million163.61%
2011 -A$16.86 Million-221.15%
2010 A$13.9 M-124.53%
2009 -A$56.71 Million-29.44%
2008 -A$80.37 Million-36.2%
2007 -A$0.13 Billion21.81%
2006 -A$0.11 Billion170.55%
2005 -A$38.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$20.03 B-34,074.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$15.97 B-27,186.06%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.95 B-49,186.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$10.83 Billion 18,258.91%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.92 B-18,627.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$9.27 Million-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.56 B-40,054.64%๐Ÿ‡บ๐Ÿ‡ธ USA